These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7773630)

  • 1. Collagen turnover in renal disease.
    Costigan M; Chambers DA; Boot-Handford RP
    Exp Nephrol; 1995; 3(2):114-21. PubMed ID: 7773630
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in serum concentrations of matrix metalloproteinases, tissue inhibitors of metalloproteinases and type IV collagen in patients with various types of glomerulonephritis.
    Akiyama K; Shikata K; Sugimoto H; Matsuda M; Shikata Y; Fujimoto N; Obata K; Matsui H; Makino H
    Res Commun Mol Pathol Pharmacol; 1997 Feb; 95(2):115-28. PubMed ID: 9090749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue inhibitor of the metalloproteinases and renal extracellular matrix accumulation.
    Jones CL; Fecondo J; Kelynack K; Forbes J; Walker R; Becker G
    Exp Nephrol; 1995; 3(2):80-6. PubMed ID: 7773641
    [No Abstract]   [Full Text] [Related]  

  • 4. Matrix metalloproteinases and their inhibitors.
    Murphy G
    Acta Orthop Scand Suppl; 1995 Oct; 266():55-60. PubMed ID: 8553862
    [No Abstract]   [Full Text] [Related]  

  • 5. The mesangial matrix in the normal and sclerotic glomerulus.
    Rosenblum ND
    Kidney Int Suppl; 1994 Feb; 45():S73-7. PubMed ID: 8158903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of the extracellular matrix components in human glomerular lesions.
    Büyükbabani N; Droz D
    J Pathol; 1994 Feb; 172(2):199-207. PubMed ID: 8169750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases expression by tubular epithelia and interstitial fibroblasts in the normal kidney and in fibrosis.
    Norman JT; Gatti L; Wilson PD; Lewis M
    Exp Nephrol; 1995; 3(2):88-9. PubMed ID: 7773643
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular analysis of glomerular diseases in renal biopsies: initial results of a collaborative international study. The International Study Group for Molecular Study of Kidney Biopsies.
    Esposito C; Striker LJ; Patel A; Peten E; Liu ZH; Sakai H; Striker GE
    Proc Assoc Am Physicians; 1996 May; 108(3):209-17. PubMed ID: 8774054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperlipidemia and glomerulosclerosis in nephropathies: clinicomorphological comparisons].
    Neverov NI; Ivanov AA
    Ter Arkh; 1994; 66(7):73-6. PubMed ID: 7985138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular cell proteoglycans: their possible role in progressive glomerular disease.
    Davies M
    Exp Nephrol; 1995; 3(2):122-6. PubMed ID: 7773631
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating type VI collagen and undulin, in patients with kidney diseases, after kidney transplantation and on hemodialysis.
    Marder K; Keller F; Schuppan D
    Clin Nephrol; 1995 Sep; 44(3):178-84. PubMed ID: 8556834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of collagen IV isoforms in experimental glomerulosclerosis.
    Bergijk EC; Van Alderwegen IE; Baelde HJ; de Heer E; Funabiki K; Miyai H; Killen PD; Kalluri RK; Bruijn JA
    J Pathol; 1998 Mar; 184(3):307-15. PubMed ID: 9614384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of collagen type VI and alpha-smooth muscle actin in renal fibrotic injury in man.
    Groma V
    Nephrol Dial Transplant; 1998 Feb; 13(2):305-12. PubMed ID: 9509439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ACE inhibitors on the expression of matrix genes and the role of p53 and p21 (WAF1) in experimental renal fibrosis.
    Morrissey JJ; Ishidoya S; McCracken R; Klahr S
    Kidney Int Suppl; 1996 May; 54():S83-7. PubMed ID: 8731201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of rutin on the extracellular matrix in streptozotocin-induced diabetic rat kidney.
    Kamalakkannan N; Stanely Mainzen Prince P
    J Pharm Pharmacol; 2006 Aug; 58(8):1091-8. PubMed ID: 16872556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine and serum levels of the carboxyterminal domain (NCl) of collagen IV in membranous glomerulonephritis and diabetic nephropathy.
    Torffvit O; Agardh CD; Alm P; Wieslander J
    Nephron; 1991; 59(1):15-20. PubMed ID: 1944730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of glomerulosclerosis: current concepts.
    Striker GE
    Nihon Jinzo Gakkai Shi; 1991 May; 33(5):447-9. PubMed ID: 1895545
    [No Abstract]   [Full Text] [Related]  

  • 18. cDNA microarray analysis of adaptive changes after renal ablation in a sclerosis-resistant mouse strain.
    Rumberger B; Vonend O; Kreutz C; Wilpert J; Donauer J; Amann K; Rohrbach R; Timmer J; Walz G; Gerke P
    Kidney Blood Press Res; 2007; 30(6):377-87. PubMed ID: 17890868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen VII expression in glomerular sclerosis.
    Onetti Muda A; Ruzzi L; Bernardini S; Teti A; Faraggiana T
    J Pathol; 2001 Oct; 195(3):383-90. PubMed ID: 11673838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of glomerular extracellular matrix and growth factor mRNA in rapid and slowly progressive glomerulosclerosis: studies in mice transgenic for native or mutated growth hormone.
    Yang CW; Striker GE; Chen WY; Kopchick JJ; Striker LJ
    Lab Invest; 1997 Apr; 76(4):467-76. PubMed ID: 9111509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.